Efficacy was assessed as change from baseline to week 16 in three co-primary endpoints : Western Ontario and McMaster Universities Osteoarthritis Index ( WOMAC ) Pain , WOMAC Physical Function and Patient 's Global Assessment ( PGA ) of OA .